Information:
Fel:
ID
34266
Beskrivning
The Norwegian Pancreas Transplantation (PTx) Study; ODM derived from: https://clinicaltrials.gov/show/NCT01957696
Länk
https://clinicaltrials.gov/show/NCT01957696
Nyckelord
Versioner (1)
- 2019-01-16 2019-01-16 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
16 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Diabetes Mellitus NCT01957696
Eligibility Diabetes Mellitus NCT01957696
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus NCT01957696
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
age ≥18 years
boolean
ID.2
Item
patients who receive a primary or secondary pancreas transplant, with or without a simultaneous kidney transplant (spk).
boolean
ID.3
Item
women who are of childbearing potential must have a negative serum pregnancy test at baseline.
boolean
ID.4
Item
operability has to be ascertained by preoperative examination, performed by nephrologist, transplant surgeon and anaesthesiologist.
boolean
ID.5
Item
signed and dated informed consent form.
boolean
ID.6
Item
evidence of systemic infection
boolean
ID.7
Item
presence of unstable cardiovascular disease.
boolean
ID.8
Item
malignancy < 5 years prior to entry into the trial (with the exception of adequately treated basal cell or squamous cell carcinomas of the skin).
boolean
ID.9
Item
panel-reactive antibodies (pra) > 20% or the presence of donor-specific antigens (dsa).
boolean
ID.10
Item
any positive test for hbv, hbc or hiv.
boolean